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Objectives: to assess the quality of life of people living with HIV/AIDS and verify its association 
with clinical characteristics and treatment adherence. Method: cross-sectional study conducted 
in a hospital in the state of Paraíba, Brazil. A questionnaire was used to collect socio-demographic 
and clinical data. The quality of life scale proposed by the World Health Organization and a 
questionnaire to measure treatment adherence were used. Results: of the 314 interviewees, 
190 (60.5%) were male, aged 43 years on average, 121 (38.5%) had attended up to five years 
of schooling, 108 (34.4%) received up to two times the minimum wage, and 112 (35.7%) were 
on sick leave. In regard to clinical variables, individuals with an undetectable viral load scored 
higher in all the domains concerning quality of life, with statistically significant differences in 
three domains. Regarding treatment adherence, 235 (73.8%) presented poor adherence and 
those who strictly adhered to treatment obtained better scores in quality of life. The results show 
that quality of life is better among individuals adherent to ART. Supporting people to adhere to 
the antiretroviral treatment should be a persistent task of healthcare workers and other people 
participating in the treatment, such as family members and friends.
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Introduction
The impact of the antiretroviral therapy (ART) 
on people with HIV/AIDS contributed to a decrease in 
mortality or HIV/AIDS-related illnesses among infected 
people(1). The number of AIDS-related deaths among 
adults and children decreased 29% since 2005. A 
decrease of 37% of AIDS-related deaths was observed 
in the last decade in Latin America(2). This decrease in 
deaths is certainly a result of therapeutic support, which 
in addition to prolonging survival, also improves quality 
of life(3).
Treatment adherence, psychological changes and 
clinical characteristics are factors directly associated 
with the quality of life (QoL) of people living with HIV/
AIDS. Consequently, there is a search not only for 
preventive and control methods, but also for strategies 
that facilitate and improve the quality of life of HIV/AIDS 
patients. Coping with HIV/AIDS means facing situations 
that can decrease or limit quality of life(1).
Health conditions, housing, safety and social 
relationships are factors that affect the quality of life of 
people living with HIV/AIDS in different respects. Quality 
of life is one of the terms with the highest multifactor 
expression, which justifies its many definitions. In this 
study, we opted for the definition of quality of life (QoL) 
proposed by the World Health Organization (WHO): 
“individuals’ perceptions of their position in life in the 
context of the culture and value systems in which 
they live and in relation to their goals, expectations, 
standards and concerns”(3-4).
In this context, the quality of life of people living 
with HIV/AIDS and its relationship with ART became an 
object of study. Many studies assess the QoL of these 
people, however, those addressing the relationship of 
QoL and ART are rare. Hence, this study’s objective 
was to assess the quality of life of people living with 
HIV/AIDS and its association with clinical factors and 
adherence to antiretroviral therapy.
Method
This analytical, cross-sectional study was conducted 
in a referral hospital for infectious diseases located in 
João Pessoa, Paraíba, Brazil.
This study included a convenience sample 
composed of 314 people living with HIV/AIDS. The 
participants were selected using the feasibility criterion 
on days care was provided in the referral hospital. 
The selection criteria included: living with HIV/AIDS, 
receiving ART for at least three months, and residing 
in the state of Paraíba, since many of this hospital’s 
patients are from other states. Data were collected 
over a period of four months (December 2012 to 
March 2013) by properly-trained research assistants. 
The study was approved by the Institutional Review 
Board at the Federal University of Paraíba (Protocol 
No. 0405/12) and all the participants signed free and 
informed consent forms.
A semi-structured questionnaire was used to 
collect socio-demographic and clinical information. 
The WHOQOL-HIV Bref(5) was used to assess Quality 
of Life. This instrument was composed of 31 items, 
divided into six domains: physical, psychological, social 
relationships, environments, level of independence, and 
religiosity(4).
The CEAT-VIH instrument (Cuestionario 
para la Evaluación de la Adhesión al Tratamiento 
Antirretroviral en Personas con Infección por VIH y 
Sida) was used to collect data related to adherence 
to ART. This instrument is composed of 20 items 
divided into two dimensions: treatment adherence 
and factors influencing treatment adherence(6). The 
minimum score is 17 and the maximum score is 89. 
In this study, the minimum score was 52 and the 
maximum was 88. In accordance with the analysis 
proposed by Remor(6), the following percentages 
(PC) were established for the questionnaire global 
score obtained by the sample: PC ≥ 85 indicates 
strict adherence (good); 50 ≤ PC < 85 indicates 
poor adherence (difficulty complying with the 
treatment); PC ≤ 49 indicate no adherence. The 
scale’s classification was used to compute the scores 
of each item of the WHOQOL HIV Bref. The internal 
consistency for the instrument domains was computed 
according to Cronbach’s coefficient of reliability.
Results
A total of 314 people living with HIV/AIDS 
participated in the study: 190 (60.5%) men and 124 
(39.5%) women, aged 43 years old on average; ages 
ranged from 21 to 70 years old. Most participants 
(110/ 35.0%) were aged between 30 and 39 years 
old. In regard to education, 193 (61.4%) participants 
attended up to ten years of schooling, while individuals 
(121/ 38.5%) who attended from one to five years 
of schooling predominated. Most participants, 190 
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(60.5%), reported being Catholic; 190 (60.5%) 
individuals reported sick leave or retirement; and 226 
(72%) individuals reported income of up to two times 
the minimum wage (Table 1).
In regard to the distribution of individuals living with 
HIV/AIDS according to clinical variables (Table 2), sexual 
intercourse was the main route of exposure to the virus 
(251/79.9%). In regard to time since diagnosis, 124 
(39.5%) individuals reported less than five years since 
diagnosis. In terms of clinical characteristics for the CD4 
T cells count, most participants (220/70.1%) had more 
than 350 cells/mm3. The viral load was undetectable for 
248 (79%) participants; from 50 to 100,000 copies per 
ml were observed for 59 (18.8%) individuals, and seven 
(2.2%) individuals presented more than 100,000 copies 
per ml (Table 2).
In regard to time since diagnosis, Table 3 shows 
that all the individuals presented higher scores in the 
psychological and spiritual domains among those 
domains concerning quality of life, according to the 
WHOQOL HIV bref.
No significant differences were found in the 
WHOQOL HIV Bref regarding the counting of CD4 T 
lymphocytes. This study found significant differences in 
the association between viral load and the psychological, 
level of independence, and environment domains. Higher 
scores in all the QoL domains were identified among 
individuals with a viral load below 50 copies per ml.
As for the presence of diseases or comorbidities in 
association with QoL domains, no significant differences 
were found, though significant association was found 
in regard to the psychological domain and previous 
diseases. The clinical variable “use of antiretroviral” did 
not present significant difference in the QoL domains, 
according to the WHOQOL HIV Bref.
When the average scores of QoL were analyzed in 
regard to therapeutic adherence (Table 4), we verified 
that the individuals classified as “non-adherent” 
presented the worst scores in all the QoL domains. 
Table 4 presented statistically significant results for the 
domains: physical, psychological, social relationships, 
religion, and the assessment using the CEAT.
Table 1 – Distribution of people living with HIV/AIDS according to socio-demographic variables, João Pessoa-PB, 
Brazil, 2012 and 2013
Variables Category
Individuals
No. of individuals (n) Percentage (%)
Sex Male 190 60.5
Female 124 39.5
Age (years) 20 to 29 25 8.0
30 to 39 110 35.0
40 to 49 92 29.3
50 to 59 64 20.4
60 to 70 23 7.3
Race Mixed 114 36.3
Not mixed 200 63.7
Education
(years of schooling)
None 27 8.6
1 to 5 years 121 38.5
6 to10 years 72 22.9
11 to 15 years 74 23.6
More than 15 years 20 6.4
Religion Catholic 190 60.5
Non-Catholic 102 32.5
No religion 22 7.0
Income (minimum wage-MW)* Less than 1 times the MW 118 37.6
From 1 to 2 times the MW 108 34.4
More than 2 times the MW 88 28.0
Occupation Employed 74 23.6
Retired 78 24.8
Sick leave 112 35.7
Unemployed 50 15.9
Total 314 100
* Minimum wage current at the time of data collection was R$ 622.00/mo.
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Table 2 – Distribution of people living with HIV/AIDS according to clinical variables, João Pessoa-PB, Brazil, 2012 and 
2013
Variables Category
Individuals
No. of individuals (n) Percentage (%)
Exposure to HIV Sexual 251 79.9
Vertical transmission 3 1.0
Blood 6 1.8
Others 54 17.2
Time since HIV diagnosis 0 to 5 years 124 39.5
6 to 10 years 98 31.2
11 to 15 years 78 24.8
More than 15 years 14 4.5
Viral load (copies per ml) < 50 (undetectable) 248 79.0
50 to 100,000 59 18.8
100,001 to 500,000 6 1.9
> 500.001 1 0.3
CD4 T cells (amount of lymphocytes cells) < 200 cells/mm3 30 9.6
200 to 350 cells/mm3 64 20.4
> 350 cells/mm3 220 70.1
Total 314 100
Table 3 – Distribution of scores of the WHOQOL- HIV Bref domains according to clinical variables of people living with 
HIV/AIDS, João Pessoa-PB, Brazil, 2012 and 2013
Clinical variables
WHOQOL HIV Bref domains
Physical Psychological Level of independence
Social 
relationships Environment
Spirituality
/Religion
Time since diagnosis 3 months to 5 
years
67.7 (18.9) 70.2 (13.1) 60.6 (15.0) 65.8 (17.5) 61.7 (15.1) 73.5 (21.2)
6 to 10 years 67.9 (20.8) 69.1 (16.7) 60.7 (17.2) 66.2 (20.4) 60.6 (15.3) 69.6 (23.2)
11 years or more 65.8 (20.9) 70.3 (16.6) 63.6 (14.8) 66.6 (18.9) 64.2 (14.7) 73.8 (21.5)
P value 0.804 0.858 0.259 0.855 0.327 0.376
CD4 T
(cell/mm3)*
< 200 69.8 (21.7) 67.0 (18.0) 56.5 (16.5) 66.3 (23.0) 57.8 (17.2) 76.0 (21.1)
200 - 350 68.1 (20.0) 70.9 (15.2) 62.9 (17.6) 66.4 (17.9) 63.5 (13.0) 71.5 (23.2)
> 350 66.6 (19.9) 70.0 (15.0) 61.8 (14.9) 66.1 (18.5) 62.3 (15.3) 72.2 (21.7)
Valor de p 0.660 0.772 0.242 0.868 0.158 0.625
Viral load (copies 
per mL)†
<50 copies per ml 68.0 (20.1) 71.2 (15.0) 62.4 (15.5) 67.0 (18.4) 63.3 (15.3) 73.3 (21.5)
≥50 copies per ml 64.4 (19.8) 64.9 (15.7) 58.0 (16.0) 62.8 (19.9) 57.7 (13.5) 68.9 (23.3)
P value 0.114 0.004‡ 0.033‡ 0.113 0.009‡ 0.163
Presence of another 
disease †
No 67.2 (20.1) 70.0 (15.4) 61.5 (15.8) 66.1 (18.8) 62.0 (15.2) 72.4 (22.2)
Yes  68.8 (19.8) 63.6 (10.3) 61.6 (9.8) 67.0 (19.0) 65.2 (10.4) 72.3 (9.4)
P value 0.953 0.133 0.947 0.988 0.538 0.702
Previous diseases† no 67.8 (19.9) 70.7 (14.8) 61.8 (15.7) 66.8 (18.8) 62.0 (15.3) 72.6 (22.2)
yes 61.5 (21.4) 62.5 (18.2) 59.0 (14.8) 60.2 (18.0) 62.9 (13.6) 70.2 (19.7)
P value 0.138 0.019§ 0.236 0.097 0.896 0.405
Use of antiretroviral 
(months)†
Up to 60 68.3 (18.3) 71.0 (12.9) 60.4 (14.4) 66.6 (17.8) 61.5 (15.2) 72.9 (21.2)
61 to 120 67.7 (22.9) 69.2 (17.7) 61.7 (17.3) 65.1 (19.9) 62.2 (15.7 ) 71.5 (24.6)
> 120 65.1 (19.6) 68.8 (16.1) 63.1 (15.6) 66.5 (19.2) 63.0 (14.4) 72.6 (20.3)
P value 0.493 0.699 0.346 0.901 0.766 0.984
*Kruskal-Wallis test (comparison of three or more independent groups).
†Mann-Whitney test (comparison of two independent samples).
Significant results: (‡) p-value< 0.01 and (§) p-value< 0.05
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Discussion
The socio-demographic characterization found 
among this study’s participants is in agreement with the 
profile of the HIV/AIDS epidemic in Brazil: men above 
older than 30 years old, with a low level of education 
and income, who were infected with HIV/AIDS through 
sexual transmission(2).
Changes in the profile of people infected with 
HIV have drawn attention. The ratio of cases between 
men and women decreased in all age groups(7). Even 
though the highest incidence of the disease is still 
observed among male individuals, recent studies show 
predominance among female individuals. Women are 
predominant in studies conducted in the South of India(8) 
and in the United States (9).
Regarding clinical variables observed in this 
study, for time since diagnosis, the highest number 
of individuals (124/39.5%) was among those who 
became aware of their HIV-positive status less than 
five years ago. Most participants presented good clinical 
parameters concerning viral load, i.e., undetectable and 
with a high number of CD4 T cells. The individuals in 
this study with undetectable viral load scored higher in 
all the QoL domains. Increased viral load aggravates the 
individual’s clinical condition, worsening symptoms and 
increasing the likelihood of hospitalization, consequently 
decreasing QoL(10). Early diagnosis is one of the aspects 
linked to a favorable prognosis for HIV/AIDS. Being aware 
of one’s serological status early on enables appropriate 
interventions and favors adherence to ART (11).
The results show that all the individuals scored 
well in the QoL domains according to clinical variables, 
especially in the psychological and spirituality domains, 
while the lowest scores were obtained in the level 
of independence and environment domains. The 
environment domain presented the lowest score 
in comparison to the other QoL domains in studies 
conducted in Brazil: Rondônia(12), Santa Catarina(13), in 
São Paulo(14) and in Porto Alegre(5).
One study developed in India reports that the 
scores obtained in QoL domains were higher in regard 
to the environment domain and lower in the domain 
concerning spirituality(8). The inverse was observed in 
this study. Spirituality was the domain with the highest 
score. Religion, spirituality, and beliefs represent a 
search for meaning in life, a search for responses to 
why and for what purpose individuals face stressful and 
difficult situations, which are considered valid aspects 
for improved QoL(15).
Spirituality provides support in times of distress, 
when there is social isolation and distance from the 
Table 4 – Distribution of scores obtained in the WHOQOL- HIV Bref domains according to adherence measured by the 
CEAT of people living with HIV/AIDS. João Pessoa - PB. Brazil. 2012 and 2013
WHOQOL domains CEAT 
+
(adherence) N valid
Average 
(scores) Average rank χ
2 statistics P value
Physical* Strict adherence 44 70.5 172.1†
Poor adherence 235 68.2 161.6† 10.522 0.005§
No adherence 35 56.4 111.9‡
Psychological* Strict adherence 44 73.5 183.8†
Poor adherence 235 71.3 164.0† 30.085 0.000§
No adherence 35 55.7 81.0‡
Level of independence Strict adherence 44 61.2 156.7
Poor adherence 235 62.6 162.4 5.065 0.079
No adherence 35 54.5 125.7
Social relationships* Strict adherence 44 72.6 183.2†
Poor adherence 235 66.2 157.6‡ 8.158 0.017||
No adherence 35 57.5 124.8†
Environment Strict adherence 44 64.1 174.2
Poor adherence 235 62.4 157.0 2.854 0.240
No adherence 35 57.5 139.6
Spirituality/
Religion*
Strict adherence 44 72.3 157.4‡
Poor adherence 235 73.9 163.0‡ 6.799 0.033||
No adherence 35 62.5 120.4†
*Kruskal-Wallis test: significant results 
†Dunn test (multiple comparisons): represent homogenous subsets
‡Dunn test (multiple comparisons): represent heterogeneous subsets
§p-value <0.01
||p-value< 0.05
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family. Religion is an important aspect providing meaning 
and order to life, suffering and distress, a result also 
found in another study(8,16). An investigation conducted in 
Ribeirão Preto, SP, Brazil with individuals co-infected with 
tuberculosis and HIV/AIDS reports that the spirituality 
domains scored higher than the other domains(17).
The total score obtained on the CEAT in this 
study was significantly correlated with the physical, 
psychological, social relationships, and spirituality/
religion domains. Low scores obtained in the physical 
domain may be associated with clinical conditions, viral 
immunosuppression or lack of ART(17).
Non-adherence to therapy, particularly among 
people living with HIV/AIDS, is a problem of greater 
magnitude. The consequences of patients’ lack of 
adherence affect not only the non-adherent individual 
but also lead to a series of problems that may reach 
the population in general. Viral suppression, decreased 
contamination, minimization of opportunistic infections, 
and reduced resistance to antiretroviral agents depend 
on therapy adherence(18).
Most of the studied sample present “poor adherence” 
and those classified as “non-adherent” obtained the 
lowest scores in all the QoL domains. The impact of non-
adherence to ART on QoL was observed in this study. 
Given the changes in mortality and morbidity, studies 
show the positive impact of adherence to ART on QoL(18).
It is known that adherence to ART improves clinical 
results, delays the progression of the disease, which in 
theory, should improve quality of life(16). One longitudinal 
study reports that adherence to ART is associated with 
improved quality of life(19). Cross-sectional studies also 
identified associations between QoL and adherence to 
ART (10,20).
When assessing the quality of life of individuals 
with HIV/AIDS and its association with ART, one needs to 
identify the individual’s clinical characteristics and which 
phase of the infection the individual is experiencing: the 
asymptomatic, symptomatic or HIV/AIDS last stage(21).
 Adherence to antiretroviral treatment may 
cause side effects in the short run (nausea and vomiting) 
and in the long run (lipodystrophy and dyslipidemia), 
impacting quality of life. One study reports no significant 
difference in the domains of QoL in association with 
the use of antiretroviral agents, but found significant 
difference in the overall assessment of health with the 
presence of adverse effects of medications(21).
The relationship between adherence to ART and 
quality of life is reciprocal. The quality of life of people 
living with HIV/AIDS may be influenced by adherence 
to ART. In this context, it is imperative to understand 
antiretroviral therapy in order to maximize its benefits 
and minimize its adverse effects (21).
Most of the participants in this study were 
asymptomatic with undetectable viral load (< 50 copies 
per ml). It can be inferred that these clinical characteristics 
influence adherence to ART and, consequently, influence 
the QoL of individuals because the absence of symptoms 
combined with the presence of undesirable side effects, 
as reported by another study, are factors that hinder 
adherence to therapy(22).
One limitation of this study is the cross-sectional 
methodological design. Despite this limitation, the 
results indicate the need to assess the influence of ART 
on QoL in this specific population. 
Conclusion
The quality of life of the studied population 
according to the WHOQOL HIV Bref was associated with 
clinical variables and adherence to antiretroviral therapy. 
Regarding the clinical variables, it is important to note 
that individuals with viral load below 50 copies per ml 
obtained the highest scores in all the QoL domains. 
As for adherence to antiretroviral therapy, individuals 
classified as “non-adherent” obtained the lowest scores 
in all the QoL domains.
Adherence to antiretroviral therapy is a positive 
factor in quality of life, especially because it improves 
immunity, controls viral load and delays the progression 
of the disease. Despite these benefits, many people 
living with HIV/AIDS have difficulty adhering to the 
therapy. Such difficulties are not only related to the 
clinical repercussions of the treatment but also due to 
difficulties accessing the service, and consequently, 
accessing medications. 
In this sense, we suggest there is a need to monitor 
the ART adherence of people living with HIV/AIDS based 
on the understanding that adherence is a continuous 
process that mainly involves the family and healthcare 
workers. In some situations, non-adherence results 
from the family and the healthcare workers themselves 
abandoning the patient. 
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